Contrast Media

  • A U.S. Food and Drug Administration (FDA) review of the safety ramifications of gadolinium-based contrast agents for magnetic resonance imaging (MRI) has not identified adverse health affects from gadolinium retained in the brain. The FDA released a drug safety communication regarding all...

  • The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recently released new recommendations on procedures employing gadolinium-based contrast agents, in which the committee recommended suspension of marketing authorization for four agents.

  • The most prevalent method for obtaining images of clogged coronary vessels is coronary angiography. For some patients, however, the contrast agents used in this process can cause health problems. A team at the Technical University of Munich (TUM) has now demonstrated that the required quantity...

  • Lantheus Medical Imaging Inc. announced U.S. Food and Drug Administration (FDA) approval of a label update for Definity Vial for (Perflutren Lipid Microsphere) Injectable Suspension. The update removes the contraindication statement related to use in patients with a known or suspected cardiac...

  • Intravenous contrast media (typically iohexol or iodixanol) used in computed tomography (CT) does not appear to be associated with chronic kidney disease, dialysis, kidney transplant or acute kidney injury, despite long-held fears to the contrary. The results of the largest controlled study of...

GE Healthcares imaging agent Visipaque, iodixanol, is now cleared for use with cardiac CT angiography, CCTA
Technology | CT Angiography (CTA) | June 16, 2017

June 16, 2017 — The U.S. Food and Drug Administration (FDA) has expanded the indication for GE Healthcare’s ...

FDA says gadolinium retention in the brain is not a safety issue
Feature | Magnetic Resonance Imaging (MRI) | May 25, 2017

May 25, 2017 — A U.S. Food and Drug Administration (FDA) review of the safety ramifications of gadolinium-based...

Targeted MRI Could Pinpoint Aggressive Prostate Cancers Before They Spread

The ZD2-Gd probe, represented by the orange ball and green arrow, binds to the EDB-FN in the prostate cancer cells with high metastatic potential. This results in a strong MRI signal (upper right). Prostate cancer cells with low metastatic potential have no EDB-FN and so there is no MRI signal (lower right). Credit: Han, et al., Bioconjug Chem-Apr-2017

News | Prostate Cancer | May 24, 2017

May 24, 2017 — A research team funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) has...

Scientists Develop Novel Chemical Dye to Improve MRI Liver Cancer Imaging
News | Magnetic Resonance Imaging (MRI) | May 03, 2017

May 3, 2017 — Scientists from the National University of Singapore (NUS) have developed a novel nanodiamond-based...

Sponsored Content | Case Study | Contrast Media Injectors | April 13, 2017

Improving Efficiency and Reducing Waste

The volume of computed tomography (CT) imaging exams continues to...

PRAC, European Medicines Agency, gadolinium-based contrast agents, safety recommendations, brain MRI
News | Contrast Media | March 13, 2017

March 13, 2017 — The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recently...

Technical University of Munich, Munich Compact Light Source, MuCLS, angiography, contrast agents

(a) Photograph of the sample in waterbath. (b) Empty image of full MuCLS beam. (c) Quasi-mono-energetic angiography image of a porcine heart acquired at the MuCLS, with iodine-based contrast agent injected into the left coronary artery. Visible are the left anterior descending artery (LAD) and the left circumflex artery (LCX). Image courtesy of the authors.

News | Angiography | March 10, 2017

March 10, 2017 — The most prevalent method for obtaining images of clogged coronary vessels is coronary...

contrast media
Feature | Contrast Media Injectors | March 02, 2017 | By Jeff Zagoudis

With medical imaging use on the rise, contrast media...

Lantheus Medical Imaging, Definity, FDA approval, label update, echocardiography, cardiac shunt contraindication
Technology | Contrast Media | February 02, 2017

February 2, 2017 — Lantheus Medical Imaging Inc. announced U.S. Food and Drug Administration (FDA) approval of a...

CT, computed tomography, IV contrast media, acute kidney injury risk, Annals of Emergency Medicine study

A new study in Annals of Emergency Medicine finds no association between intravenous contrast media used in computed tomography (CT) and kidney damage. Roughly 80 million doses of IV contrast media are given every year. Credit: American College of Emergency Physicians

News | Contrast Media | January 30, 2017

January 30, 2017 — Intravenous contrast media (typically iohexol or iodixanol) used in...

Videos | Magnetic Resonance Imaging (MRI) | December 12, 2016

Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of...

Bracco Diagnostics, CT Exprès 3-D Contrast Media Delivery System, RSNA 2016, computed tomography
Technology | Contrast Media Injectors | December 05, 2016

December 5, 2016 — Bracco Diagnostics Inc. announced that CT Exprès — the first and only multi-dose, multi-patient,...

GE Healthcare, Optison ultrasound contrast agent, FDA labeling change, cardiac shunts, intra-arterial injection
Technology | Contrast Media | October 04, 2016

October 4, 2016 — GE Healthcare announced that the U.S. Food and Drug Administration (FDA) has approved a label...

contrast-enhanced ultrasound, CEUS, liver cancer, hepatocellular carcinoma, study, Advances in Contrast Ultrasound conference, ICUS
News | Ultrasound Imaging | September 12, 2016

September 12, 2016 — Tiny microbubbles are being used to more effectively...

Toshiba, Aplio 500 Platinum ultrasound, International Contrast Ultrasound Society, ICUS, live case, contrast-enhanced
News | Ultrasound Imaging | September 07, 2016

September 7, 2016 — Toshiba America Medical Systems Inc. announced that its Aplio 500 Platinum...

gadolinium, ACR Manual on Contrast Media, update, FDA safety concerns
News | Contrast Media | July 12, 2016

July 12, 2016 — The updated American College of Radiology (ACR) Manual on Contrast Media contains a statement...

MRI, gadolinium contrast, Parkinsonism, nervous system disorder, Blayne Welk, Western University
News | Contrast Media | July 05, 2016

July 5, 2016 — A study appearing in the July 5 issue of JAMA assessed the association between...

News | Magnetic Resonance Imaging (MRI) | June 01, 2016

June 1, 2016 — Alzeca Biosciences announced successful preliminary results for ADx, its novel, proprietary...

Overlay Init